Summary
A number of drugs are available that act fairly specifically as ‘mild’ analgesics, although this description by no means implies that their clinical effectiveness is limited to the relief of slight painand trivial disability. They are effective by mouth and their action is mediated peripherally. Among the possible mechanisms of action, the inhibition of prostaglandin synthesis is currently regarded as most likely to be relevant. Some centrally acting drugs of the narcotic analgesic type, such as codeine and dextropropoxyphene are effective orally; they are usable in the same way as other mild analgesics and may be preferable for some types of pain.
Many problems arise in the assessment and comparison of mild analgesics, both experimentally and clinically. Subjective assessments may be made on a pain scale by the patient himself, or by a trained observer. Individual variations are all-important, and the limitations of controlled trials need to be remembered.
Alternative drugs and mixtures have little advantage over aspirin, but specific drug tolerance, in the long term, varies from patient to patient. Gastric irritation is most likely to occur with aspirin in the presence of chronic dyspepsia or acute precipitating causes such as alcoholic gastritis. Allergy also occurs in some susceptible individuals. The risk of renal damage with phenacetin is increasingly appreciated, and the possibility of hepatic damage from paracetamol is now recognised. Other side-effects and interactions are summarised in the review, and some notes are given on therapeutic and non-therapeutic use.
Similar content being viewed by others
References
Avery, G.S.: Check list to potentially clinically important interactions. Drugs 5: 187–211 (1973).
Beaver, W.T.; Wallenstein, S.L.; Houde, R.W. and Rogers, A.: A comparison of the analgesic effects of parenteral methadone and morphine, and of oral and parenteral methadone, in patients with cancer. Clinical Pharmacology and Therapeutics 8: 415–426(1967).
Beecher, H.K.: Pain in men wounded in battle. Annals of Surgery 123: 96–105 (1946).
Beecher, H.K.: in The Measurement of Subjective Responses (Oxford University Press, London 1959).
Beecher, H.K.: in Clinical Evaluation of Analgesic Drugs. Acta Anaesthesiologica Scandinavica, Supplement 25: 323–324(1966).
Bellville, J.W.; Forrest, W.H. and Brown, B.W.: Clinical and statistical methodology for co-operative clinical assays of analgesics. Clinical Pharmacology and Therapeutics 9: 290–302 (1968a).
Bellville, J.W.; Forrest, W.H.; Elashoff, Janet and Laska, E.: Evaluating side-effects of analgesics in a co-operative clinical study. Clinical Pharmacology and Therapeutics 9: 303–313 (1968b).
Benson, R.E. and Boleyn, T.: Paracetamol overdosage: A plan of management. Anaesthesia and Intensive Care 4: 334–339 (1974).
Brody, T.M.: Action of sodium salicylate and related compounds in tissue metabolism in vitro. Journal of Pharmacology and Experimental Therapeutics 117: 39–51(1956).
Chafee, F.H. and Settipane, G.A.: Aspirin intolerance. I. Frequency in an allergic population. Journal of Allergy and Clinical Immunology 53: 193–199 (1974).
Clouet, D.H.: in Narcotic drugs: Biochemical Pharmacology (Plenum Press, New York 1971).
Collier, H.O.J.: in Dixon et al. (Eds) Salicylates: An International Symposium (Churchill, London 1963).
Collier, H.O.J.: A pharmacological analysis of aspirin. Advances in Pharmacology and Chemotherapy 7: 333–405 (1969).
Collier, H.O.J.; Dinneen, L.C.; Johnson, C.A. and Schneider, C: The abdominal constriction response and its suppression by analgesic drugs in the mouse. British Journal of Pharmacology 32: 295–310 (1968).
Collier, H.O.J.; Hammond, A.R.; Horwood-Barrett, S. and Schneider, C: Rapid induction by acetylcholine, bradykinin and potassium of a nociceptive response in mice and its selective antagonism by aspirin. Nature 204: 1316–1318(1964).
Collier, H.O.J. and Shorley, P.G.: Analgesic antipyretic drugs as antagonists of bradykinin. British Journal of Pharmacology 15: 601–610(1960).
Conney, A.H.; Sansur, M.; Soroko, F.; Koster, R. and Burns, J.J.: Enzyme induction and inhibition in studies on the pharmacological actions of aceto-phenetidin. Journal of Pharmacology and Experimental Therapeutics 151: 133–138 (1966).
Dordoni, B.; Willson, R.A.; Thompson, R.P.H. and Williams, R.: Reduction of absorption of paracetamol by activated charcoal and cholestyramine: A possible therapeutic measure. British Medical Journal 3: 86–87 (1973).
Dreser, H.: Pharmakologisches über aspirin (acetylsali-cylsäure). Pflugers Archives ges. Physiology 76: 306–318(1899).
Editorial: Aspirin and what else? British Medical Journal 3: 5–6 (1974).
Eichenholz, A.; Mulhausen, R.O. and Redleaf, P.S.: Nature of acid-base disturbance in salicylate intoxication. Metabolism 12: 164–175 (1963).
Ellis, E.S.: in Ancient Anodynes (Heinemann, London 1946).
Ferreira, S.H.; Mancada, S. and Vane, J.R.: Indomethacin and aspirin abolishes prostaglandin release from the spleen. Nature 231: 237–239 (1971).
Finck, A.D. and Katz, R.L.: Prevention of cholera-induced intestinal secretion in the cat by aspirin. Nature 238: 273–274 (1972).
Flower, R.J. and Vane J.R.: Inhibition of prostaglandin synthetase in brain explains the antipyretic activity of paracetamol (40-acetamidophenol). Nature 240: 410–411 (1972).
Forrest, J.A.H.; Roscoe, P.; Prescott, L.F. and Stevenson, I.H.: Abnormal drug metabolism after barbiturate and paracetamol overdose. British Medical Journal 4: 499–502 (1974).
Gilman, A.: Analgesic nephrotoxicity. A pharmacological analysis. American Journal of Medicine 36: 167–173(1964).
Gross, M. and Greenberg, L.A.: in The Salicylates. A critical bibliographic review (Hillhouse Press, New Haven 1948).
Guzman, F.; Braun, C. and Lim, R.K.S.: Visceral pain and the pseudaffective response to intra-arterial injection of bradykinin and other algesics agents. Archives International Pharmacodynamics 136: 353–384(1962).
Guzman, F.; Braun, C.; Lim, R.K.S.; Potter, G.D. and Rodgers, D.W.: Narcotic and non-narcotic analgesics which block visceral pain evoked by intra-arterial injection of bradykinin and other algesic agents. Archives International Pharmacodyanmics 149: 571–588(1964).
Hart, F.D. (Ed.): in The Treatment of Chronic Pain (Medical and Technical Publishing Co., Lancaster 1974).
Havill, J.H.: Malignant hyperthermia caused by salicylate overdosage associated with phenelzine therapy — a case report. Anaesthesia and Intensive Care 4: 380–383 (1974).
Head, H.: On disturbances of sensation with especial reference to the pain of visceral disease. Brain 16: 1–130(1893).
Houde, R.W.: Assessment of analgesic activity; in Way (Ed.) New Concepts in Pain and its Clinical Management (F.A. Davis and Co., Philadelphia 1967).
Huskisson, E.C.: Simple analgesics for arthritis. British Medical Journal 4: 196–200 (1974).
Jollow, D.J.; Mitchell, J.R.; Potter, W.Z.; Davis, D.C.; Gillette, J.R. and Brodie, B.B.: Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. Journal of Pharmacology and Experimental Therapeutics 187: 195–202 (1973).
Keele, K.D.: The pain chart. Lancet 2: 6–8 (1948).
Lester, D.; Lolli, G. and Greenberg, L.A.: The fate of acetylsalicylic acid. Journal of Pharmacology 87: 329–342 (1946).
Levy, G.: Comparison of dissolution and absorption rates of different commercial aspirin tablets. Journal of Pharmaceutical Sciences 50: 388–392 (1961).
Levy, G.: Effect of certain tablet formulation factors on dissolution rate of the active ingredient. I. Importance of using appropriate agitation intensities for in vitro dissolution rate measurements to reflect in vivo conditions. Journal of Pharmaceutical Sciences 52: 1039–1046 (1963).
Levy, G.; Antkowiak, J.M.; Procknal, J.A. and White, D.C.: Effect of certain tablet formulation factors on dissolution rate of the active ingredient. II. Granule size, starch concentration, and compression pressure. Journal of Pharmaceutical Sciences 52: 1047–1051 (1963).
Levy, G. and Gumtow, R.H.: Effect of certain tablet formulation factors on dissolution rate of the active ingredient. III. Tablet lubricants. Journal of Pharmaceutical Sciences 52: 1139–1144 (1963).
Levy, G. and Hollister, L.E.: Failure of U.S.P. disintegration test to assess physiologic availability of enteric coated tablets. New York State Journal of Medicine 64: 3002–3005 (1964).
Lewis, J.W.; Bentley, K.W. and Cowan, A.: Narcotic analgesics and antagonists. Annual Review of Pharmacology 11: 241–270(1971).
Lim, R.K.S.; Guzman, F.; Rodgers, D.W.; Goto, K.; Braun, C; Dickerson, G.D. and Engle, R.J.: Site of action of narcotic and non-narcotic analgesics determined by blocking bradykinin-evoked visceral pain. Archives International Pharmacodynamics 152: 25–58(1964).
Livingston, W.K.: in Pain Mechanisms (Macmillan, New York 1947).
Loan, W.B. and Morrison, J.D.: Strong analgesics: Pharmacological and therapeutic aspects. Drugs 5: 108–143 (1973).
McCleave, D.J. and Havill, J.: A review of acute salicylate poisoning. Anaesthesia and Intensive Care 4: 340–344 (1974).
Mackenzie, J.: Some points bearing on the association of sensory disorders and visceral disease. Brain 16: 321–354(1893).
MacLagan, T.: The treatment of acute rheumatism by salicin. Lancet 1: 342–343 and 383–385 (1876).
Macklon, A.F.; Craft, A.W.; Thompson, M. and Kerr, D.N.S.: Aspirin and analgesic nephropathy, British Medical Journal 1: 597–600 (1974).
Major, C.T. and Pleuvry, B.J.: Effects of a-methyl-p-tyrosine, p-chloro-phenylalanine, L-β(3,4-dihydroxyphenyl) alanine, 5-hydroxy-tryptophan and diethyldithiocarbamate on the analgesic activity of morphine and methylamphetamine in the mouse. British Journal of Pharmacology 42: 512–521 (1971).
Mehta, M.: in Intractable Pain (Saunders, London 1973).
Melzack, R. and Wall, P.D.: Pain mechanisms: A new theory. Science 150: 971–978 (1965).
Mills, D.G.; Borda, LT.; Philp, R.B. and Eldridge, C: Effects of in vitro aspirin on blood platelets of gastrointestinal bleeders. Clinical Pharmacology and Therapeutics 15: 187–192(1974).
Mitchell, J.R.; Jollow, DJ.; Potter, W.Z.; Davis, D.C.; Gillette, J.R. and Brodie, B.B.: Acetaminophen-induced hepatic necrosis I. Role of drug metabolism. Journal of Pharmacology and Experimental Therapeutics 187: 185–194(1973).
Murray, R.M.: Analgesic nephropathy: Removal of phenacetin from proprietary analgesics. British Medical Journal 4: 131–132(1972).
Murray, R.M.; Lawson, D.H. and Linton, A.L.: Analgesic nephropathy: Clinical syndrome and prognosis. British Medical Journal 1: 479–482 (1971).
New Zealand Rheumatism Association Study: Aspirin and the kidney. British Medical Journal 1: 593–596 (1974).
O’Reilly, R.A.; Sahud, M.A. and Aggeler, P.M.: Impact of aspirin and chlorthalidone on the pharmacodynamics of oral anticoagulant drugs in man. Annals of the New York Academy of Sciences 179: 173–186(1971).
Papper, E.M.; Brodie, B.B. and Rovenstine, E.A.: Postoperative pain: Its use in the comparative evaluation of analgesics. Surgery 32: 107–109 (1952).
Parkhouse, J.: Recording and analysis of clinical data. British Journal of Anaesthesia 39: 35–37 (1967).
Parkhouse, J.; Collie, J.A. and Wood, V.: A study of aspirin and nepenthe. British Journal of Anaesthesia 39: 38–49(1967).
Parkhouse, J. and Hallinon, P.: A comparison of aspirin and paracetamol. British Journal of Anaesthesia 39: 146–154(1967).
Parkhouse, J.; Heppenstall, C; Smith, E. and Wright, V.: An attempt to evaluate a rapidly acting oral analgesic. Canadian Medical Association Journal 100: 1057–1058(1969).
Parkhouse, J.; Lambrechts, W. and Simpson, B.R.J.: The incidence of postoperative pain. British Journal of Anaesthesia 33: 345–353 (1961).
Parkhouse, J.; Rees-Lewis, M.; Skolnik, M. and Peters, H.: The clinical dose response to aspirin. British Journal of Anaesthesia 40: 433–441 (1968).
Prescott, L.F.: Effects of acetylsalicylic acid, phenacetin, paracetamol and caffeine on renal tubular epithelium. Lancet 2: 91–96 (1965).
Prescott, L.F.: Clinically important drug interactions. Drugs 5: 161–186(1973).
Prescott, L.F.; Newton, R.W.; Swainson, C.P.; Wright, N.; Forrest, A.R.W. and Matthew, H.: Successful treatment of severe paracetamol overdosage with cysteamine. Lancet 1: 588–592 (1974).
Prescott, L.F. and Wright, N.: The effects of hepatic and renal damage on paracetamol metabolism and excretion following overdosage. A pharmacokinetic study. British Journal of Pharmacology 49: 602–613 (1973).
Proudfoot, A.T. and Wright, N.: Acute paracetamol poisoning. British Medical Journal 4: 557–558 (1970).
Rees, G.J.; Stead, A.L. and Bush, G.H.: Salicylate poisoning. British Medical Journal 2: 1454 (1960).
Rogers, A.: Pain and the cancer patient. Nursing Clinics of North America 2: 671–682 (1967).
Schreiner, G.E.: The nephrotoxicity of analgesic abuse. Annals of Internal Medicine 57: 1047–1052 (1962).
Segar, W.E. and Holliday, M.A.: Physiologic abnormalities of salicylate intoxication. New England Journal of Medicine 259: 1191–1198(1958).
Settipane, G.A.; Chafee, F.H. and Klein, D.E.: Aspirin intolerance. II A prospective study in an atopic and normal population. Journal of Allergy and Clinical Immunology 53: 200–204 (1974).
Singer, R.B.: The acid-base disturbance in salicylate intoxication. Medicine 33: 1–13 (1954).
Smith, G.M.; Egbert, L.D. and Beecher, H.K.: The submaximal effort tourniquet method of producing experimental pain in man: Sensitivity to 5mg of morphine and 0.6gr of aspirin. Federation Proceedings (Abstract) 25: 501, No. 2 part 1 (1966).
Smith, J.B. and Willis, A.L.: Aspirin selectively inhibits prostaglandin production in human platelets. Nature 231: 235–237 (1971).
Smith, M.J.H. and Smith, P.K. (Eds): in The Salicylates: A critical bibliographic review (Interscience Publishers, New York 1966).
Smith, P.K.; Gleason, H.L.; Stoll, C.B. and Orgorzalek, S.: Studies on the pharmacology of salicylates. Journal of Pharmacology 87: 237–255 (1946).
Starr, M.S. and West, G.B.: Bradykinin and oedema formation in heated paws. British Journal of Pharmacology 31: 178–187 (1967).
Sunshine, A.; Laska, E.; Meisner, M. and Morgan, S.: Analgesic studies of indomethacin as analysed by computer techniques. Clinical Pharmacology and Therapeutics 5: 699–707 (1964).
Swerdlow, M. (Ed): in Relief of Intractable Pain (Excerpta Medica, Amsterdam 1974).
Türker, K. and Kiran, B.K.: The antagonistic effect of noramidopyrine methanesulfonate on some pharmacological actions of the synthetic bradykinin. Arzneimittel-Forschung 14: 1318–1319(1964).
Vane, J.R.: Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs. Nature 231: 232–235(1971).
Vane, J.R.: Prostaglandins and the aspirin-like drugs. Hospital Practice 7: 61–67 (1972).
Winter, CA.: in Garattini and Dukes (Eds) Non-Steroidal Anti-inflammatory Drugs. (Excerpta Medica, Amsterdam 1965).
Winters, R.W.; White, J.S.; Hughes, M.C. and Ordway, N.K.: Disturbances of acid-base equilibrium in salicylate intoxication. Pediatrics 23: 260–285 (1959).
Woodbury, D.M.: Analgesics and antipyretics; in Goodman and Gilman (Eds) The Pharmacological Basis of Therapeutics 3rd edition (Macmillan, New York 1968).
Wright, N. and Prescott, L.F.: Paracetamol overdosage: Potentiation of hepatotoxicity by previous drug therapy. Scottish Medical Journal 18: 56–59 (1973).
Yu, T.F. and Gutman, A.B.: Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms of excretion of urate in man. Journal of Clinical Investigation 38: 1298–1315(1959).
Author information
Authors and Affiliations
Additional information
See subject index in each issue for further indexing terms.
Rights and permissions
About this article
Cite this article
Parkhouse, J. Simple Analgesics. Drugs 10, 366–393 (1975). https://doi.org/10.2165/00003495-197510050-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-197510050-00007